Browse by author
Lookup NU author(s): Professor Andrew Pearson,
Emeritus Professor Alan Craft,
Dr Jennifer Kernahan,
Professor Kim Bartlett
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Whole body protein synthesis and catabolism were measured using the [ring-2H5]phenylalanine and [l-13C]leucine primed constant infusion technique in 32 paediatric patients with cancer at different stages of treatment. Rates of synthesis (S) and catabolism (C) derived from the [ring-2H5]phenylalanine and [l-13]leucine models were 4.7 (SD 1.3) (S) and 6.0 (1.5) (C) g/d/kg, and 5.5 (0.8) (S) and 6.8 (1.2) (C) g/d/kg, respectively. These results show that these two tracer techniques give similar results in this study population. Comparison of these values with results previously reported for groups of control children using the [ring-2H5]phenylalanine model (S = 3.69 and 3.93; C = 4.09 and 4.28 g/d/kg) and the [l-13C]leucine model (S = 4.32; C = 4.85 g/d/kg) show that rates of synthesis and catabolism were higher in cancer patients than in controls. Thus whole body protein turnover is increased in children under treatment for cancer. Other indices of metabolism such as plasma amino acids and intermediary metabolites were also measured and showed that, although subjects were in isotopic steady state, there were significant metabolic changes during the course of the primed constant infusions used to measure protein turnover.
Author(s): Daley, S. E., Pearson, A. D. J., Craft, A. W., Kernahan, J., Wyllie, R. A., Price, L., Brock, C., Hetherington, C., Halliday, D., Bartlett, K.
Publication type: Article
Publication status: Published
Journal: Archives of Disease in Childhood
Print publication date: 01/10/1996
ISSN (print): 0003-9888
ISSN (electronic): 1468-2044
PubMed id: 8984910
Altmetrics provided by Altmetric